Quantcast
Channel: New Drug Approvals
Viewing all articles
Browse latest Browse all 2871

Daiichi partners with AZ to sell Movantik in US…….Pharmatimes, Selina McKee

$
0
0
Naloxegol.svg
Naloxegol
Daiichi partners with AZ to sell Movantik in US 
March 19, 2015

Selina McKee

News editor, Selina McKee

Selina McKee

Qualified from King’s College London with BSc (hons) in Human Biology in 1999 with an interest in medical journalism. Has since held positions as a database analyst managing a portfolio of companies at Evaluate Pharma, and as news editor at Pharma Marketletter. Fluent German speaker, interests include music, piano, reading, astronomy, photography and Formula 1.

Daiichi partners with AZ to sell Movantik in US

AstraZeneca has chosen Daiichi Sankyo to help sell its novel constipation drug Movantik (naloxegol) in the US, as the firm gears up for its launch in April.

First-in-class Movantik was cleared in the US last September for the treatment of opioid-induced constipation in adults with chronic non-cancer pain, for which there is still significant unmet need.

PharmaTimes Magazine and Digital offer a unique blend of news stories, interviews, features, case studies, analysis and comment on the critical issues facing the pharma and healthcare sectors. Our wide editorial lens combined with our editorial philosophy to deliver sharp, informed and entertaining coverage from the perspective of the industry, the payer and the patient, allows PharmaTimes to help kickstart conversations that matter most to our audience of decision makers within pharma and the healthcare profession.PharmaTimes Competitions are a critical facet of our business, providing a unique opportunity for industry to showcase its most talented people in marketing, communications, sales and clinical research. No other competitions offer entrants the chance to compete head-to-head in real-life challenges devised by independent industry and healthcare experts, to test their skill sets against their peers in real time, and receive feedback to ensure the whole experience is a valuable learning process.

 Selina McKee

Selina McKee

Editor, UK News at PharmaTimes

London, United Kingdom
Pharmaceuticals
uk.linkedin.com/pub/selina-mckee/4/174/339/en

Experience

Editor, UK News

PharmaTimes

September 2005 – Present (9 years plus

Company News Editor

Pharma Marketletter

November 2003 – August 2005 (1 year 10 months)

Research Analyst

Evaluate Pharma

March 2000 – January 2003 (2 years 11 months)

Education

King’s College London, U. of London

BSc (Hons) Human Biology

1996 – 1999

PharmaTimes Media Ltd.
8-10 Dryden Street
Covent Garden
London WC2E 9NA

Email: pharma@pharmatimes.com
Telephone: +44 (0)20 7240 6999
Fax: +44 (0)20 7240 4479

Company Registration Number: 09019637

Selina McKee

Map of Dryden St, London WC2E 9NA, UK
Dryden St London WC2E 9NA, UK

Registered in England & Wales at:
PharmaTimes Media Limited
8-10 Dryden Street
Covent Garden
London WC2E 9NA

more………….

LINKEDIN

uk.linkedin.com/pub/selina-mckee/4/174/339/en

Authors – PharmaTimes

Selina McKee. Qualified from King’s College London with BSc (hons) in Human Biology in 1999 with an interest in medical journalism. Has since held positions .

Selina McKee (@PTSelinaMcKee) | Twitter

The latest Tweets from Selina McKee (@PTSelinaMcKee). News Editor for http://t.co/o6l54nzsxb & PharmaTimes Magazine. Also on your mobile. Sussex, UK.

5 Dryden Street, Covent Garden, London. London – , Greater London, WC2

Covent Garden Interior May 2006

covent garden. 2 Dryden Street. London

Dryden Street, London
.
Happy Hands provides domestic cleaning in Covent Garden (WC2) and other districts in London.

Filed under: COMPANIES Tagged: ASTRAZENECA, AZ, Daiichi, Movantik, naloxegol, partners, Pharmatimes, Selina McKee, us

Viewing all articles
Browse latest Browse all 2871

Trending Articles



<script src="https://jsc.adskeeper.com/r/s/rssing.com.1596347.js" async> </script>